Modelling cyclic moisture uptake in an epoxy adhesive

This paper presents a methodology for predicting moisture concentration in an epoxy adhesive under cyclic moisture absorption-desorption conditions. The diffusion characteristics of the adhesive were determined by gravimetric experiments under cyclic moisture conditions and the dependence of diffusion coefficient and saturated mass uptake on moisture history was determined. Non-Fickian moisture absorption was observed during absorption cycles while moisture desorption remained Fickian. The diffusion coefficient and saturated moisture content showed variation with absorption-desorption cycling. A finite element-based methodology incorporating moisture history was developed to predict the cyclic moisture concentration. A comparison is made between the new modelling methodology and a similar method that neglects the moisture history dependence. It was seen that the concentration predictions based on non-history dependent diffusion characteristics resulted in over-prediction of the moisture concentration in cyclic conditioning of adhesive joints. The proposed method serves as the first step in the formulation of a general methodology to predict the moisture dependent degradation and failure in adhesives

Moisture absorption-desorption effects in adhesive joints

This paper presents a study of moisture absorption-desorption effects in single lap adhesive joints. Experiments were carried out to characterise the moisture uptake of the single part epoxide adhesive, FM73. Tensile testing of single lap joints manufactured from aluminium alloy 2024 T3 and O and FM73 adhesive was carried out after the joints were exposed to different conditioning environments. The experimental results revealed that the failure strength of the single lap joints with 2024 T3 adherends progressively degraded with time when conditioned at 50°C, immersed in water. However, the joint strength almost completely recovered after moisture was desorbed. The single lap joints with 2024 O adherends showed decreased strength for 28 days of conditioning, after which strength recovered, reaching a plateau after 56 days. Again, strength almost completely recovered on desorption of moisture. The strength recovery of the joints, after desorption of moisture, showed that the degradation of the adhesive was largely reversible. Analysis of the failure surfaces revealed that the dry joints failed cohesively in the adhesive layer and that the failure path moved towards the interface after conditioning. The failure mode then reverted back to cohesive failure after moisture desorption

Simulation of a Standard Store Separated from Generic Wing

Evaluation of store separation experimentally is expensive; time consuming and dangerous as human risks are involved. This results in development of computational methods to simulate the store separation. Store separation studies include store separation simulation and determination of linear and angular displacements of store under the influence of complex and non-uniform flow field of parent aircraft. In order to validate the methodology, the unsteady CFD results, obtained by coupling six degrees of freedom (6-DOF) with flow solver, are compared with experimental results. Major trends are captured which are consistent with experimental results. Variation in store trajectory has been evaluated with different combinations of forward and rearward ejection forces. By increasing the magnitude of forward ejection force vertical displacement increases and store separates more safely from the wing. Moreover, effects of varying parent wing configuration on store trajectory has also been analyzed by incorporation of leading-edge flaps (LEFs). Store always separates in nose down condition due to LEFs which increases vertical displacement of store and thus safety related to store separation is enhanced

(2S)-3-(1H-Indol-3-yl)-2-(4-methyl­benzene­sulfonamido)­propionic acid monohydrate

In the title compound, C18H18N2O4S·H2O, the indole and toluene ring systems are oriented at a dihedral angle of 84.51 (9)°. In the crystal, the components are linked by N—H⋯O, O—H⋯O, C—H⋯O and N—H⋯π inter­actions. These include a short link from the α-C atom of the amino acid fragment

Improvement in the Mechanical Properties of High Temperature Shape Memory Alloy (Ti 50

High temperature shape memory alloys Ti50Ni25Pd25 and Ti50Ni20Pd25Cu5 were developed, characterized, and tensile tested in both martensite ( Mf − 50°C) and austenite ( Af + 50°C) phases. The transformation temperatures of ternary Ti50Ni25Pd25 alloy were increased by 11 to 12.5°C by substitution of Ni with 5 at% Cu. At the same time, transformation heat absorbed and released during forward and reverse martensitic transformation was also increased. In the martensite phase, the mechanical properties, that is, the stress for reorientation of martensite variants and fracture stress, were increased by 33 and 60 MPa, respectively, whereas the fracture strain was decreased by 1.5%. In the austenite phase, the critical stress for slip and fracture stress were increased by 62 and 40.9 MPa, respectively, whereas the fracture strain was decreased by 1.2%. The increase in both stresses was attributed to the solid solution strengthening by substitution of Ni atoms with relatively greater atomic radius of copper (Cu) atoms. The overall results suggest that the addition of 5 at% Cu in place of Ni in Ti50Ni25Pd25 alloy is very beneficial to improving the mechanical and shape memory properties and increasing the transformation temperatures

Lipid-Polymer Hybrid Nanoparticles for Controlled Delivery of Hydrophilic and Lipophilic Doxorubicin for Breast Cancer Therapy

Background: Lipid polymer hybrid nanoparticles (LPHNPs) for the controlled delivery of hydrophilic doxorubicin hydrochloride (DOX.HCl) and lipophilic DOX base have been fabricated by the single step modified nanoprecipitation method. Materials and methods: Poly (D, L-lactide-co-glicolide) (PLGA), lecithin, and 1,2-distearoyl-Sn-glycero-3-phosphoethanolamine-N-[methoxy (polyethylene glycol)-2000 (DSPE-PEG 2000) were selected as structural components. Results: The mean particle size was 173–208 nm, with an encapsulation efficiency of 17.8±1.9 to 43.8±4.4% and 40.3±0.6 to 59. 8±1.4% for DOX.HCl and DOX base, respectively. The drug release profile was in the range 33–57% in 24 hours and followed the Higuchi model (R2,=0.9867–0.9450) and Fickian diffusion (n<0.5). However, the release of DOX base was slower than DOX.HCl. The in vitro cytotoxicity studies and confocal imaging showed safety, good biocompatibility, and a higher degree of particle internalization. The higher internalization of DOX base was attributed to higher permeability of lipophilic component and better hydrophobic interaction of particles with cell membranes. Compared to the free DOX, the DOX.HCl and DOX base loaded LPHNPs showed higher antiproliferation effects in MDA-MB231 and PC3 cells. Conclusion: Therefore, LPHNPs have provided a potential drug delivery strategy for safe, controlled delivery of both hydrophilic and lipophilic form of DOX in cancer cellsPeer reviewe

Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

Background: This study provides a global overview of the management of patients with acute cholecystitis during the initial phase of the COVID-19 pandemic. Methods: CHOLECOVID is an international, multicentre, observational comparative study of patients admitted to hospital with acute cholecystitis during the COVID-19 pandemic. Data on management were collected for a 2-month study interval coincident with the WHO declaration of the SARS-CoV-2 pandemic and compared with an equivalent pre-pandemic time interval. Mediation analysis examined the influence of SARS-COV-2 infection on 30-day mortality. Results: This study collected data on 9783 patients with acute cholecystitis admitted to 247 hospitals across the world. The pandemic was associated with reduced availability of surgical workforce and operating facilities globally, a significant shift to worse severity of disease, and increased use of conservative management. There was a reduction (both absolute and proportionate) in the number of patients undergoing cholecystectomy from 3095 patients (56.2 per cent) pre-pandemic to 1998 patients (46.2 per cent) during the pandemic but there was no difference in 30-day all-cause mortality after cholecystectomy comparing the pre-pandemic interval with the pandemic (13 patients (0.4 per cent) pre-pandemic to 13 patients (0.6 per cent) pandemic; P = 0.355). In mediation analysis, an admission with acute cholecystitis during the pandemic was associated with a non-significant increased risk of death (OR 1.29, 95 per cent c.i. 0.93 to 1.79, P = 0.121). Conclusion: CHOLECOVID provides a unique overview of the treatment of patients with cholecystitis across the globe during the first months of the SARS-CoV-2 pandemic. The study highlights the need for system resilience in retention of elective surgical activity. Cholecystectomy was associated with a low risk of mortality and deferral of treatment results in an increase in avoidable morbidity that represents the non-COVID cost of this pandemic